Clinical
Trials
Finder
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Search
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Conditions
Oligometastatic Prostate Cancer (OMPC)
New York, New York
Oligometastatic Prostate Cancer (OMPC) Clinical Trials in New York, New York
1 recruiting
New York, New York
Showing
1–1
of
1
trials
Recruiting
Phase 3
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
Oligometastatic Prostate Cancer (OMPC)
Novartis Pharmaceuticals
450 enrolled
142 locations
NCT05939414
Feedback